Kayla Rena Joyner

6PUBLICATIONS
4CO-AUTHORS
Decision makingPredictive and prognostic markersTraditional Chinese medicine and treatmentsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 28, 2022
Reply: Baricitinib Versus Tocilizumab for the Treatment of Moderate to Severe COVID-19.

Temeka Dawn Lewis-Wolfson, Kayla Rena Joyner

|Oct 31, 2022
Baricitinib Versus Tocilizumab for the Treatment of Moderate to Severe COVID-19.

Nancy Kierstin Reid, Kayla Rena Joyner, Temeka Dawn Lewis-Wolfson

|Oct 13, 2022
Atogepant for the prevention of episodic migraine in adults.

Maranda Paige Switzer, Joseph Edward Robinson, Kayla Rena Joyner

|Oct 18, 2021
Eptinezumab: A calcitonin gene-related peptide monoclonal antibody infusion for migraine prevention.

Kelsey Woods Morgan, Kayla Rena Joyner

|Sep 30, 2020
Novel Therapies in Acute Migraine Management: Small-Molecule Calcitonin Gene-Receptor Antagonists and Serotonin 1F Receptor Agonist.

Kayla Rena Joyner, Kelsey Woods Morgan

|Jul 11, 2020
Comparison of Narrow-Versus Broad-Spectrum Antibiotics in Elderly Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease.

Kayla R Joyner, Autumn Walkerly, Kelsey Seidel

Pageof 1

Frequent Collaborators

2 joint publications

Kelsey Woods Morgan

2 joint publications

Temeka Dawn Lewis-Wolfson

1 joint publications

Autumn Walkerly

1 joint publications

Mate M Soric